RLT
Renergen Limited
🇦🇺 ASX
⚡️ ENERGY
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-3.87%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Renergen Ltd. operates as an investment holding company, which engages in the provision of alternative and renewable energy sectors. The firm is a liquid helium and liquefied natural gas (LNG) producer. The company is focused on delivering helium and domestic natural gas in South Africa and Sub-Saharan Africa. The firm's segments include Tetra4, Cryovation and Corporate head office. Tetra4 segment explores for, develops and sells compressed natural gas (CNG) to the South African market. Cryovation segment consists of Cryo-Vacc technology, which enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. The Company’s projects include Virginia Gas project (Tetra4). Its Tetra4 project comprises exploration and production rights of approximately 187 000 hectares (ha) of CNG fields across Welkom, Virginia and Theunissen, in the Free State Province and Mpumalanga Province in the town of Evander.
📈 Performance
Price History
+6.88%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.85
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RLT
7
📊 Total Capital Earnings
$37K
🔃 Average investment frequency
34 weeks
💵 Average investment amount
$957
⏰ Last time a customer invested in RLT
57 days
RLT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
25%
50k - 100k
50%
Less than 50k
25%
👶 Age of investors
18 - 25
26 - 34
86%
35 - 90
14%
🙋 Legal gender of investors
Female
29%
Male
71%
Pearlers who invest in RLT also invest in...
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.51%
📊 Share price
$66.23 AUD
🕊️ SOCIALLY AWARE
⛳️ DIVERSIFIED
🌏 GLOBAL
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.75%
📊 Share price
$102.44 AUD
⛳️ DIVERSIFIED
💸 FINANCIALS
🇦🇺 AUSTRALIA
🧱 MATERIALS
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
4.18%
📊 Share price
$137.95 AUD
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
💸 FINANCIALS
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
🙌 Performance (5Yr p.a)
12.90%
📊 Share price
$14.77 AUD
🇦🇺 EX AUSTRALIA
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
HGEN.AX was created on 2021-10-06 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Global Hydrogen ESG Index.
📊 Share price
$4.42 AUD
🏭 INDUSTRIALS
🇦🇺 EX AUSTRALIA
Want more shares? Try these...
Resimac Group Ltd. engages in the provision of mortgage origination and management of home loans. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-03-19. Its fully integrated business model comprises originating, servicing and funding prime, non-conforming residential mortgages and asset finance products in Australia and New Zealand. The company is focused on originating and servicing a loan portfolio, supported by a global funding program. The company offers a full suite of lending products to consumers and commercial borrowers across its subsidiaries. These products include residential home loans, consumer finance and small and medium enterprise finance. The company also offers home loans directly to consumers via its homeloans.com.au brand, with a range of smart and transparent home loan solutions that borrowers can apply for using its end-to-end online application. CustomerZone is its online loan management platform where customers can manage their home loan. The company provides solutions to a range of customers, including self-employed, contractors, and customers.
🙌 Performance (5Yr p.a)
-0.66%
📊 Share price
$0.88 AUD
💸 FINANCIALS
💰 HIGH DIVIDEND
RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,140 full-time employees. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.
🙌 Performance (5Yr p.a)
16.17%
📊 Share price
$35.23 AUD
🌳 ENVIRONMENTAL
🕊️ SOCIALLY AWARE
🩺 HEALTH CARE
📈 HIGH PRICE GROWTH
